Back
Open Access

Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452

Session: New developments in anti thrombotic drug therapy
Topic: Antiplatelet Drugs
Speaker: Professor L. Jennings (Memphis, US)
Event: ESC CONGRESS 2019

Congress Session

0

About the speaker

Professor Lisa Jennings

MLM Medical Labs, LLC, Memphis (United States of America)
0 follower

3 more presentations in this session

State of the Art - Novel targets in anti thrombotic drug development

Speaker: Associate Professor B. Rocca (Rome, IT)

Access
Slides
Video
0
Thumbnail

Novel direct thrombin inhibitor achieves superior antithrombotic effect with lower bleeding risk than heparin or bivalirudin

Speaker: Assistant Professor C. Koh (Singapore, SG)

Access
Abstract
Slides
Video
0
Thumbnail

Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients

Speaker: Professor R. Storey (Sheffield, GB)

Access
Abstract
Slides
Video
0
Thumbnail

Access the full session

New developments in anti thrombotic drug therapy

Speakers: Professor L. Jennings, Associate Professor B. Rocca, Assistant Professor C. Koh, Professor R. Storey
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk